FoxM1 is a promising candidate target in the treatment of breast cancer.

Lu, Xiao-Feng; Zeng, De; Liang, Wei-Quan; Chen, Chun-Fa; Sun, Shu-Ming; Lin, Hao-Yu

Lu, Xiao-Feng; Zeng, De; Liang, Wei-Quan; Chen, Chun-Fa; Sun, Shu-Ming; Lin, Hao-Yu.

Afiliación

Lu XF; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Zeng; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.
Liang WQ; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Chen CF; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Sun SM; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Lin HY; Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

Oncotarget ; 9(1): 842-852, 2018 Jan 02.

Article en En | MEDLINE | ID: mdl-29416660

Palabras clave

FoxM1; breast cancer; prognostic values

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google